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A huge technological pivot is going on in crop breeding. If the end of the 20th century was 
the era of transgenic breeding or GMO technologies, the 21st century is silently turning 
to non-transgenic breeding or non-GMO technologies. Due to significant regulatory 
 issues, cost of development and technology constraints, transgenic breeding technologies 
have been limited to a few crops grown on large acreages, i.e. about 10% of the available 
cultivated acres globally1. The promise of non-transgenic breeding technologies is their 
extraordinary breadth. Crops bred using these technologies can be planted on all farming 
acreage worldwide. And these technologies can address better, more novel non-transgenic 
traits both in large- and in small-acreage crops. Small crops are accessible because the 
development cost is so much less than for transgenic crops. 
This shift to non-transgenic technologies has been led by advances in precision gene-
editing technologies that include molecular scissors such as CRISPRs (clustered regularly 
interspaced short palindromic repeats) and TALENs (transcription activator-like effector 
nucleases), bolstered by the explosion in genome-sequence information. Our understand-
ing puts us at the threshold of a new era in non-transgenic crop breeding. With powerful 
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advances in crop-breeding technologies at the core of this silent revolution in crop breeding, 
these new technologies will enable the development of new traits more rapidly and more 
precisely. Because of their promise, these powerful technologies are quickly becoming 
the most important tool to ensure global food security through sustainable agriculture 
in the foreseeable future. 
Cibus is a non-transgenic-trait-development company at the apex of this revolution. 
With a proprietary technology built over more than a decade, Cibus has a large and broad 
patent portfolio in this space (over 170 issued or pending). Cibus has developed precision 
gene-editing platforms for a variety of crops that are accurate and predictable with reliable 
timelines. As opposed to younger companies just starting to work with these technolo-
gies, Cibus has a broad product line both in commercialization and in development. This 
revolution in agriculture, food and microbes promises both to address the growing needs 
for a safe and sustainable food future and to replace the need for the current transgenic 
technologies that, today, dominate the industry. Cibus is a leader in this revolution.
Overview
Technology and an understanding of genetics has been at the core of accelerating plant 
breeding (Figure 1). Articulated by Gregor Mendel, single traits were tracked as visible 
phenotypes from one generation to the next, with outcomes limited by the genetic diversity 
available within the parental lines. To increase this diversity, various classical mutagenesis 
techniques were employed, including the treatment of whole plants, seeds or tissue pieces 
with various DNA-damaging chemicals (e.g., ethyl methanesulfonate [EMS]) or radiation 
(e.g., gamma radiation). This approach helped to address one of the limitations of tradi-
tional breeding, the wait time for new mutations, thus accelerating the breeding process. 
That said, the mutations obtained are random, so influencing specific outcomes was not 
possible with this method. Currently more than 2,500 such products in 180 crops are sold 
in commerce without labeling or other restrictions applied (http://www.fao.org). Many 
characteristics of current crops, such as orange- and yellow-colored sweet peppers, are the 
result of this process, known as chemical mutagenesis or mutation breeding.
With advancements in the field of molecular biology, marker-assisted selection (MAS) 
enabled the development of complex traits leveraging both existing variation among all 
available lines of a crop and that induced using classical mutagenesis approaches. The 
marker is a small piece of DNA that always coexists in a plant with the desired trait or a 
proportion of that desired trait. By quickly and easily identifying plants containing the 
marker associated with the desired trait, the breeding process is faster and more efficient 
using MAS. MAS is, however, limited by the diversity that exists in the crop already. If 
the trait does not exist in the crop, there is no way to breed for it using MAS.
The development of transgenic techniques, inserting DNA foreign to the plant, begin-
ning in the late 1970s, enabled movement of entire genes to generate single traits. Initial 
transgenic traits used genes from bacteria or other non-plant sources; however, transgenic 
traits can also be developed by inserting genes from wide crosses that could not occur in 
nature. Although extremely powerful, the location at which the transgene lands is ran-
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dom, occurring in well expressed and less well expressed regions of the genome alike. To 
ensure the appropriate level of transgene expression requires that many transgenic lines be 
 assessed for the trait’s performance. Random transgene insertion may inactivate an existing 
gene, one that is critical for some aspect of the crop’s development, therefore agronomic 
performance of the crop must also be assessed. Even when this does not occur, because a 
completely new sequence (the transgene) is present on one arm of a chromosome pair, it 
may reduce recombination frequency at that point, making it difficult to reduce linkage 
drag associated to the new locus.
Gene-editing techniques, including Cibus’ Rapid Trait Development System (RTDSTM), 
enable the development of non-transgenic traits with laser precision. These traits can be 
developed more rapidly, with extremely reduced cost and global consumer acceptance.
RTDS in Plants
Gene editing has been a holy grail in biology with technology to obtain precisely tar-
geted mutations being explored for almost 40 years. Initially, work to develop precise 
single-nucleotide polymorphisms (SNPs) focused on simpler and less-complex plasmid 
DNA targets (Hutchison et al., 1978). A decade later, Fred Sherman used chemically 
 synthesized oligonucleotides to achieve targeted mutations in yeast (Saccharomyces cere-
visiae) (Moerschell et al., 1988).
As early as 1998, oligonucleotides were used to achieve targeted mutations in the genome 
of the gut bacterium Escherichia coli (Zhang et al., 1998). Then, with the advent of the 
lambda-Red system, precise targeting in E. coli became routine in 2001 and, by 2011, 
improvements in that technology enabled more than 10 SNPs to be targeted simultane-
ously in a single genome (Isaacs et al., 2011). These were combined by breeding to obtain 
more than 300 targeted mutations within a single genome (Isaacs et al., 2011). 
In 1996, oligonucleotides were first used in mammalian cells, initially to correct an 
episome (Yoon et al. 1996), and then within the nuclear genome to correct the point 
Figure 1. History of plant breeding from Mendel to today.
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mutation in the human β-globin gene that causes sickle-cell anemia (Cole-Strauss et al., 
1996). At that time, since the oligonucleotide chemistry used was an RNA/DNA hybrid 
molecule, the first generation of the RTDS technology was termed chimeraplasty. 
A few years later in the first application in plants, chimeraplasty was used to target 
the acetolactate synthase (ALS) gene in a tobacco cell line known as Nt-1 (Beetham et 
al., 1999). The enzyme encoded by this gene target is responsible for the biosynthesis of 
branched-chain amino acids including leucine, isoleucine and valine. By targeting this 
gene the researchers were able to modify it, allowing the cells to become herbicide resistant. 
The herbicide in this example belonged to a class known as sulfonylureas. Included in this 
report was evidence that RTDS could also modify a transgene (a marker gene known as 
GFP—green fluorescent protein—introduced transgenically into either tobacco cells or 
whole plants). The researchers were able to reactivate an inactivated form of this gene.
This work was further supported by a complementary study by researchers at Pioneer 
Hi-Bred, Inc., who modified a similar gene in maize (Zhu et al., 1999, 2000). They 
modified the tobacco ALS homolog in maize known as the acetohydroxyacid synthase 
(AHAS) gene. The converted cells were also herbicide resistant. Additionally, they modified 
a GFP transgene in maize. Modified cells were then cultured, and plants were regenerated 
and allowed to mature. The subsequent progeny of these plants confirmed that the gene 
mutations were heritable and stable.
Kochevenko and Willmitzer (2003) also confirmed the utility of RTDS to modify 
plant genes by repeating and extending the work of Beetham et al. (1999) with the ALS 
gene in tobacco with a more extensive study that included the regeneration of whole 
plants from cells that had undergone RTDS conversion. Sequence analysis and enzyme 
assays showed that the DNA had been converted at the target site and the ALS enzyme 
was resistant to the herbicide. Applying chlorsulfuron to the regenerated tobacco plants 
confirmed that the herbicide-tolerant phenotype exhibited Mendelian inheritance. This 
paper confirmed that the gene-repair oligonucleotide (GRON) -targeted mutations are 
distinct and precise. Further, Okuzaki and Toriyama (2004) also targeting the AHAS 
gene, successfully converted two independent sites in rice, selecting with chlorsulfuron 
and bispyribac.
Trait-Development Process—Herbicide Tolerance in Canola
Cibus has used conversion of a visible marker gene to GFP in the model system Arabi-
dopsis, canola and other crops, yielding improvements in conversion efficiency of up to 
three orders of magnitude.
One method of practicing RTDS involves regenerating protoplasts to whole plants. 
By applying the process described in Figure 2, mutations were obtained in canola AHAS 
homologs, one of which was key to developing Cibus’ herbicide-tolerant SU CanolaTM 
product, which is currently in the launch phase in the United States.
Despite over a decade of experience in continuously improving the canola cell-culture 
system, the latest technology advancements have made this process twice as fast and 16 
times more efficient. This provides opportunities to greatly accelerate project timelines 
and has made non-selectable changes a reality.
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RTDS Conversion ProCess—GRONs are Chemically Synthesized 
Directed Mutagens
GRON structure and chemistry are designed purposefully. The GRON is designed with 
a mismatch in one or a few bases compared to the target gene’s sequence. GRONs are 
chemically synthesized structures consisting of both DNA and modified nucleotides or 
other end-protective chemistries. The GRON is blocked from undergoing recombination 
due to its chemical structure, with the GRON acting as a mutagen and RTDS being a 
targeted mutagenesis system and not a transgenic or GM process. Company scientists, 
through their understanding of the target gene’s sequence, design the GRON to effect 
(a) specific sequence change(s), the replacement, insertion or deletion of nucleotides. 
GRONs are produced with an automated chemical synthesizer and purified like any other 
chemical agent; they contain no biologically derived material. The GRON is formulated 
without the need for a delivery vector, which ensures that no foreign or extraneous DNA 
is inserted into the plant.
Over the years, scientists have continued to actively work on RTDS, focusing on 
understanding the mechanism to help optimize GRON design. Incrementally, altera-
tions in design have been developed and tested. In our standard bacterial assay, GRONs 
are orders of magnitude more efficient, than our original designs. The efficiency in the 
Figure 2. RTDS process to develop herbicide tolerance in canola.
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bacterial assay has also translated to higher efficiencies in eukaryotic cells, i.e., plant, 
mammalian and yeast.
Mechanism of GRON Action
RTDS is a mutagenesis technology that uses the natural or inherent mismatch-repair 
system to effect a change. In eukaryotic cells, the GRON crosses the cell membrane, 
traverses the cytoplasm to the nucleus, locates and binds selectively and specifically to its 
target sequence and effects (a) specific sequence change(s) in its target gene. Nucleases 
and other degrading enzymes in the cells then break down the GRON (Figure 3).
A working model of the RTDS mechanism has emerged from studies in bacteria and 
mammalian cells. These studies suggest that the GRON will modify the nucleotide 
sequence in the genome via a process of genome/GRON “pairing” followed by GRON-
directed mismatch repair (Figure 3). In E. coli, studies by Cibus scientists have clearly 
shown that the process is mutS- and recA-dependent. These two proteins are an integral 
part of the cell’s own endogenous repair system. Rice et al. (2000) and Gamper et al. 
(2000) have shown that cell-free extracts from a variety of plants—including banana, 
corn and tobacco—were able to precisely modify a target-DNA sequence and that mu-
tation efficiency varied with the chemistry of the supplied GRON. Among others, the 
effects of chemistry of single-strand GRONs have also been studied by Andrieu-Soler 
et al. (2005), Radecke et al. (2006), and de Piédoue et al. (2007), showing that some 
designs are toxic, leading to delayed progression through the cell cycle and, in some cases, 
selective apoptosis.
Figure 3. RTDS conversion process.
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This mismatch signals the cell’s “mismatch” repair system to change the gene’s sequence 
such that the mismatched nucleotide is removed enzymatically, and the new sequence of 
the gene is resynthesized with the GRON acting as the template over the targeted portion 
of the gene. The working model that has emerged from studies in bacteria, yeast and mam-
malian cells indicates that the GRON will modify the nucleotide sequence in the genome 
via a process of genome/GRON “pairing” and then GRON-directed DNA repair.
Once inside the cell, the GRON is transported to the nucleus and hybridizes to the 
targeted gene sequence. Specific hybridization is a critical step for determining the ef-
ficiency of the gene-correction process. The GRON would then be used as the template 
for a DNA polymerase to correct the removed nucleotide or nucleotides, thereby pro-
ducing a continuous sequence using the cell’s own source of nucleotides. The ability of 
the GRON to specifically hybridize with great affinity to its target, and its resistance to 
degradation, allows the cellular gene-repair mechanism time to locate and replace, insert 
or delete the targeted DNA nucleotide(s) on both strands of the genomic DNA. When 
the DNA strands are corrected to the GRON’s DNA sequence, the GRON is degraded 
and the gene then functions under its natural control mechanisms.
Regulatory Considerations 
Using RTDS, new traits can be added to a plant with only very minor changes to the genes 
and their resulting proteins. Results presented above show single-nucleotide substitutions 
in the AHAS gene lead to tolerance to three classes of AHAS inhibitors. The resulting 
plants are substantially equivalent to non-converted plants, with no risk of allergenicity 
or toxicity. Further, the GRON-induced mutation is made within the native pattern of 
expression for the target gene. There is no possibility that flanking genes may have expres-
sion patterns altered in unexpected ways.
In 2004, the USDA confirmed that RTDS is a modern form of mutagenesis and should 
not be regulated by state or federal agencies. In the United States, Cibus’ commercial SU 
Canola product is now in the launch phase. In Canada, in late 2013, Cibus and its part-
ner BASF received PNT (plant with novel trait) approvals for herbicide-tolerant canola. 
Work is underway to develop and register hybrids for the Canadian market as well as to 
achieve herbicide registration.
In Europe, RTDS is known as oligo-directed mutagenesis (ODM). Towards assess-
ing ODM, in 2011, an Expert Working Group on Novel Plant Breeding Techniques, 
appointed by the European Commission, concluded that RTDS should be treated as 
mutagenesis and excluded from regulation under 2001/18/EC. This position has been 
endorsed by recent reports from a number of Member State advisory groups, including 
ZKBS in Germany and ACRE in the United Kingdom. 
Opportunities—Broad Applicability Across Multiple Organisms 
This technology can be used in a multitude of applications including repair of gene de-
fects and mutations that modify genes and, therefore, their protein functions. Extensive 
research, at Cibus and by academic scientists, has demonstrated the successful application 
of the GRON-directed gene repair or gene mutation in human, animal, yeast, plant, and 
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bacterial cells, both in culture (in vitro) and in live animals, plants, yeast and bacteria (in 
vivo). Therefore, a large number of genes in a wide spectrum of living organisms appear 
to be accessible to RTDS through a commercially viable process.
Conclusions
Cibus’ technologies are the core of our Rapid Trait Development System (RTDS). They 
have been developed over the past decade, focused on the molecular and cellular aspects 
of obtaining targeted spelling changes in target genes. Molecular aspects have focused on 
characterizing gene targets, mutation discovery to achieve desired traits in these targets as 
well as developing and improving our single-nucleotide polymorphism (SNP) screening 
technology. Cell-biology aspects have focused on developing crop platforms that enable 
SNPs to be obtained efficiently in single cells and regenerating those cells into normal 
fertile plants—plants that are the same as the parent with one or a few precisely targeted 
SNPs. Speed to market for future products has been cut materially because of advances 
in Cibus’ technologies and with our systematized approach. These advances mean:
• Precision in trait modification
• Faster product-development timelines 
• A proven and reproducible methodology for trait development
• Clear regulatory path
Due to technology constraints, development costs and regulatory hurdles, the current 
transgenic technologies have fallen short and cannot meet the needs of the market. In 
order to meet what has been reported as a doubling in global food production by 2050, 
we need a reliable method. This is the promise of precision gene editing for non-transgenic 
crop breeding. This is the promise of Cibus.
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WitH an extensive background in molecular biol-
ogy, Greg Gocal has been central in developing the 
RTDS technology in plant and microbial systems. 
Currently, he leads the technology group at Cibus, 
and is part of the senior executive team tasked with 
exploring the many commercial opportunities to 
deliver on RTDS’ potential applications. In the past, 
he has focused primarily on developing the molecular 
aspects of the technology, including target character-
ization, mutation discovery, molecular screening and assay development. Also, 
he has played a key role in the development of Cibus’ first commercial product, 
SU Canola (sulfonylurea tolerant), and in helping achieve regulatory approval 
for this trait in Canada. Over the past decade, his research leadership has led to 
multiple commercial partnerships for the company. In addition, his experience 
has expanded to include the development of key intellectual property through 
to products moving to market.
Dr. goCal has authored numerous peer-reviewed publications, several book 
chapters and is a co-inventor of many applications within Cibus’ patent estate. 
He earned a BSc in biochemistry/botany and an MSc in plant physiology from 
the University of Calgary, and received his PhD in plant molecular biology from 
the Australian National University.
